References
- Alexander DJ, Collins CJ, Coombs DW, et al. (2008). Association of Inhalation Toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals. Inhal Toxicol 20:1179–89
- Cheng Y, Bowen L, Rando R, et al. (2010). Exposing animals to oxidant gases: nose only vs. whole body. Proc Am Thorac Soc 7:264–8
- Cryan S, Sivadas N, Garcia-Contreras L. (2007). In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev 59:1133–51
- Data Sciences International. (2015). The allay restraint. Available from: http://www.datasci.com/products/buxco-respiratory-products/allay-restraint. [Last accessed: 04 Aug 2015]
- Driscoll K, Costa D, Hatch G, et al. (2000). Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 55:24–35
- Fernandes C, Vanbever R. (2009). Preclinical models for pulmonary drug delivery. Expert Opin Drug Deliv 6:1231–45
- Forbes B, Asgharian B, Dailey L, et al. (2011). Challenges in inhaled product development and opportunities for open innovation. Adv Drug Deliv Rev 63:69–87
- Kaur J, Muttil P, Verma RK, et al. (2008). A hand-held apparatus for exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages. Eur J Pharm Sci 34:56–65
- Liu F, Li W, Pauluhn J, et al. (2013). Lipopolysaccharide-induced acute lung injury in rats: Comparative assessment of intratracheal instillation and aerosol inhalation. Toxicology 304:158–66
- Mainelis G, Seshadri S, Garbuzenko OB, et al. (2013). Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice. J Aerosol Med Pulm Drug Deliv 26:345–54
- Nahar K, Gupta N, Gauvin R, et al. (2013). In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur J Pharm Sci 49:805–18
- Patton J, Bryon P. (2007). Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67–74
- Pauluhn J, Mohr U. (2000). Inhalation studies in laboratory animals-current concepts and alternatives. Toxicol Pathol 28:734–53
- Pauluhn J. (2005). Overview of inhalation exposure techniques: strengths and weaknesses. Exp Toxicol Pathol 57:111–28
- Phalen RF, Mannix RC, Drew RT. (1984). Inhalation exposure methodology. Environ Health Perspect 56:23–34
- Raeburn D, Underwood S, Vilamil M. (1992). Techniques for drug delivery to the airways, and the assessment of lung function in animal models. J Pharmacol Toxicol Methods 27:143–59
- Sakagami M. (2006). In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58:1030–60
- Sellers S, Horodnik W, House A, et al. (2015). The in vitro and in vivo investigation of inhaled migraine therapies using a novel aerosol delivery system consisting of an air pressurized capsule device (APCD) in combination with a pMDI spacer for endotracheal dosing into beagle dogs. Drug Dev Ind Pharm. [Epub ahead of print]
- Sinha B, Mukherjee B. (2012). Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model. Drug Dev Ind Pharm 38:171–9